Inspire’s Post

So... Lots going on re EMR analysis / AI for patient recruitment, but we still know that building relationships with potentially eligible patients / onboarding the right way is so important (shout out to the great study coordinators and PIs out there!). Is EMR analysis the main game? Is better patient onboarding the main game? Please check out (and like/promote) my latest column in Applied Clinical Trials that focuses on challenges / debates in clinical trial recruitment. Special thanks to Brett Kleger and Elisa Cascade for their contributions!

Are you ready to rethink how we approach patient recruitment in clinical trials? Hugo Stephenson, CEO of TrialScreen in his first installment as a regular contributor in Applied Clinical Trials Magazine, dove deep into the critical question: Is clinical trial recruitment primarily a data problem or a trust challenge? He sat down with two industry leaders to unpack this complex issue: Brett Kleger, CEO of Inspire, shared a powerful insight: "While data can tell us who might be eligible, it doesn't necessarily tell us who will participate. There's a human element that can't be captured by algorithms alone." Elisa Cascade, Chief Product Officer at Advarra, added nuance, noting that the approach varies by trial type: "One of the greatest drivers of clinical trial interest was a patient's lack of satisfaction with their medication, including bothersome side effects." Read the full article ➡ https://bit.ly/3ACPI4t At TrialScreen, we're committed to bridging the gap between data-driven insights and trust-based relationships in North America, Latin America and Asia/Pacific. Our mission is to create more inclusive and efficient trials that accelerate the development of life-changing therapies. Join us in transforming the landscape of clinical trial recruitment! #ClinicalTrials #PatientRecruitment #DataAndTrust #HealthTech #TrialScreen

"The future of effective clinical trial recruitment lies in the synergy between data-driven approaches and trust-building efforts" - Hugo Stephenson on patient recruitment and the balance needed between different strategies, including emphasising how important it is to understand participant motivation in the disease area/type of trial.

Clinical trial recruitment is a tough task. On one hand, we can access the insights from thousands of data points to assist recruitment. But on the other hand, participants need to trust clinical trials. While TrialScreen uses technology to enable recruitment, computers and algorithms do not replace everything that we do. Check out Hugo's article for more.

Optimizing Clinical Trials for Better Medical Research Clinical trials are the backbone of modern medicine, but they're often slow and costly. By optimizing trial design, patient recruitment, data collection, and more, we can speed up the process and bring new treatments to patients faster. 🩺 🔬 🔸 Adaptive trial designs 🔸 Targeted patient recruitment 🔸 Advanced data collection methods 🔸 Collaborative platforms 🔸 Early regulatory engagement 🔸 AI-driven data analysis 🔸 Virtual trials Read more about these strategies and their benefits > https://shorturl.at/ba7uv #ClinicalTrials #MedicalResearch #Innovation #Healthcare

[NEW ON OUR BLOG] With the recent announcement of our CEO as a PharmaVoice Top 100 Winner in the clinical trial pros category, we're sharing how we're transforming trials. Our Clinical Trials Engagement Manager, Olivia Woodford-Berry, explains how #RWD and #AI are making an impact from trial design to patient recruitment. Read more: https://hubs.la/Q02Wh8Pp0

Citeline has just launched a new product for my patient engagement & recruitment network, PatientMatch. This product uses RWD and sophisticated algorithms to connect patients with trials. The landscape of clinical trials is changing, and the time to find the right patients to join your clinical trials is getting shorter. I've included a link to our press release below, any questions on how this offering can support your recruitment efforts, please reach out! #clinicaltrials #patientrecruitment

Transforming Patient Recruitment: The Hidden Link to Breakthrough Clinical Trial Success https://lnkd.in/ePw8iqe4 #Technology #ClinicalResearch #ClinicalTrials #PatientRecruitment #DigitalMarketing

SEQSTER partners with Antidote Technologies for clinical trial enrollment - MobiHealthNews #SEQSTER Partners with Antidote Technologies for Clinical Trial Enrollment SEQSTER, a leading healthcare data management platform, has announced a partnership with Antidote Technologies to streamline clinical trial enrollment. This collaboration aims to improve patient recruitment and engagement in clinical research studies. #Enhancing Patient Recruitment with Technology By leveraging SEQSTER's data aggregation capabilities and Antidote's patient matching technology, healthcare providers can identify eligible patients for clinical trials more efficiently. This partnership will enable healthcare organizations to reach a broader patient population and accelerate the recruitment process. #Improving Clinical Trial Participation Rates With the integration of SEQSTER and Antidote's platforms, healthcare IT professionals can enhance patient engagement and facilitate informed decision-making regarding clinical trial participation. This collaboration will ai.mediformatica.com #clinical #clinicaltrial #data #seqster #clinicaltrials #platform #digital #patients #dataplatform #better #dataintegration #digitalpatient #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4bzBUnB)

Recruitment challenges in clinical trials remain a significant hurdle, even after years of innovation. Competing trials, overburdened sites, and increasingly complex trial designs make patient enrollment a persistent challenge. This insightful article from Applied Clinical Trials explores strategies to improve patient recruitment outcomes, including leveraging real-world data, enhancing site engagement, and prioritizing diversity in trial populations. It emphasizes the importance of collaboration across stakeholders to address these longstanding issues. What resonates with me is how these challenges have persisted for so long, despite advances in technology and trial planning. Addressing them will require a focus on patient-centric strategies and smarter use of data to navigate competing trials and strained resources. What strategies or tools have you found effective in addressing these challenges? Let’s discuss! 👉 Read the article here: https://lnkd.in/g9FtYrba